Dengue Diagnostics The Right Test at The Right Time For The Right Group 1St Edition Shamala Devi Sekaran Online Ebook Texxtbook Full Chapter PDF
Dengue Diagnostics The Right Test at The Right Time For The Right Group 1St Edition Shamala Devi Sekaran Online Ebook Texxtbook Full Chapter PDF
https://ebookmeta.com/product/practical-stoicism-exercises-for-
doing-the-right-thing-right-now-grey-freeman-2/
https://ebookmeta.com/product/practical-stoicism-exercises-for-
doing-the-right-thing-right-now-grey-freeman/
https://ebookmeta.com/product/decision-making-in-aesthetic-
practice-the-right-procedures-for-the-right-patients-1st-edition-
vincent-wong/
https://ebookmeta.com/product/alt-right-not-right-1st-edition-
nick-griffin/
The Right Fit Nicole Pyland
https://ebookmeta.com/product/the-right-fit-nicole-pyland/
https://ebookmeta.com/product/right-across-the-world-the-global-
networking-of-the-far-right-and-the-left-response-1st-edition-
john-feffer/
https://ebookmeta.com/product/the-right-call-1st-edition-sally-
jenkins/
https://ebookmeta.com/product/the-right-resolution-1st-edition-
kristen-ethridge/
https://ebookmeta.com/product/mr-right-as-rain-mr-right-1-1st-
edition-haley-travis/
DENGUE DIAGNOSTICS
DENGUE DIAGNOSTICS
The Right Test at the Right Time
for the Right Group
edited by
Shamala Devi Sekaran
Published by
Jenny Stanford Publishing Pte. Ltd.
101 Thomson Road
#06-01, United Square
Singapore 307591
Email: [email protected]
Web: www.jennystanford.com
Dengue Diagnostics: The Right Test at the Right Time for the
Right Group
Copyright © 2024 by Jenny Stanford Publishing Pte. Ltd.
All rights reserved. This book, or parts thereof, may not be reproduced in any form
or by any means, electronic or mechanical, including photocopying, recording
or any information storage and retrieval system now known or to be invented,
without written permission from the publisher.
For photocopying of material in this volume, please pay a copying fee through
the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923,
USA. In this case permission to photocopy is not required from the publisher.
Preface vii
Selected Protocols 95
Index 103
Preface
Dengue Diagnostics: The Right Test at the Right Time for the Right Group
Edited by Shamala Devi Sekaran
Copyright © 2024 Jenny Stanford Publishing Pte. Ltd.
ISBN 978-981-4968-97-3 (Hardcover), 978-1-032-66956-4 (eBook)
www.jennystanford.com
2 Introduction to Dengue and Issues with Current Diagnostics
Figure 1.1 Geographical distribution of dengue cases reported worldwide, May to July, 2022.
Diagnosis 5
1.2 Diagnosis
Dengue can be diagnosed clinically; however, laboratory tests are
required to confirm the infection. Definitive diagnosis is important
not only for the clinical management of patients, but also for
interventions during outbreaks, epidemiological surveillance, and
for vaccine development and monitoring. The development of assays
is ongoing and newer assays using more advanced technologies
have been developed, though not fully validated. The main hurdle
lies in the incompletely understood pathogenesis of dengue and
that multiple sequential infections occur in dengue-endemic areas,
notwithstanding the issues with primary and secondary infection
status that further complicate the diagnosis. Therefore, for a
diagnostic assay to be useful and effective, it is essential for users
to have some degree of confidence in the test in order to improve
disease management, especially in the acute early stage and for
detecting signs of severity. An ideal dengue diagnostic test would
be one that is simple, rapid, with high sensitivity and specificity,
preferably able to differentiate between primary and secondary
infections, serotype the virus, and most important of all affordable.
The optimal time frame for diagnosis would be from the onset to
10 days post-infection. In reality, more than half only consult the
physician when in dire situations, with many people in third-world
countries resorting to traditional healing. It is also important to note
that 2% do not seroconvert and a large number are asymptomatic.
Diagnostic tools currently are mainly serologically based,
nucleic acid-based, or antigen detection. A good understanding
of the clinical conditions of dengue patients is essential for the
appropriate usage of these tests. The highest confidence lies in the
isolation of the virus, thus fulfilling Koch’s postulate, detection by
direct immunofluorescence (IF), and genome amplification via
PCR (Medina et al., 2012; Prescott, Feldmann, & Safronetz, 2017;
Salles et al., 2018; World Health Organization, 2009), or detection
of viral antigens like NS1 using either ELISAs or rapid lateral flow
tests (Chong et al., 2020; Guzman, Jaenisch et al., 2010; Hunsperger
et al., 2009; Kumarasamy, Chua et al., 2007; Kumarasamy, Wahab et
al., 2007; Peeling et al., 2010; S. D. Sekaran, Lan, & Subramaniam,
2018; Shamala Devi, 2008; Tricou et al., 2010; Wang & Sekaran,
2010b, 2010a). However, more often than not we tend to use tests
6 Introduction to Dengue and Issues with Current Diagnostics
out of convenience and hence look for antibodies, and for these,
diagnostically useful results are best obtained using paired samples.
Currently, virus isolation, PCR, and direct IF are carried out only in
reference and research laboratories. NS1, however, is more user-
friendly, and apart from ELISAs, rapid flow tests have been developed
and validated. These, however, are useful in the first 5 days of
symptoms when viremia still exists. Serology can also be utilized
by demonstrating a seroconversion from negative to positive IgM
antibody to dengue, or a four-fold or greater increase in IgG antibody
titers in paired (acute and convalescent) serum specimens. Patients
who are IgM positive and PCR negative are usually classified as recent
probable dengue infection as IgM antibodies to dengue remain
elevated for 90 days after the illness and could have been from an
infection that occurred 2–3 months ago. In addition, it is important
to note that cross-reactivity with other flaviviruses including West
Nile virus (WNV), St. Louis encephalitis virus (SLE), Japanese
encephalitis virus (JEV), Zika virus, and yellow fever virus (YFV)
do occur and hence a review of the patient’s past medical history,
recent travel history, and vaccination record (especially yellow fever
vaccination) are needed to determine the likelihood that the current
acute febrile illness is actually due to an infection with dengue
virus. In many instances, a paired sample is best utilized to make
a diagnosis, especially for those who present late after the onset of
illness (> 5 days), as virus and viral antigens become undetectable,
and in these instances, the tests need to be carried out on all viruses
suspected. The current infection will be the only pair demonstrating
a four-fold rise (Schilling, Ludolfs, Van An, & Schmitz, 2004; Shamala
Devi Sekaran & Soe, 2017).
References
Changal, K. H., Raina, A. H., Raina, A., Raina, M., Bashir, R., Latief, M., …
Changal, Q. H. (2016). Differentiating secondary from primary dengue
using IgG to IgM ratio in early dengue: An observational hospital based
clinico-serological study from North India. BMC Infectious Diseases,
16(1), 715. https://doi.org/10.1186/s12879-016-2053-6
Chong, Z. L., Sekaran, S. D., Soe, H. J., Peramalah, D., Rampal, S., & Ng, C.-W.
(2020). Diagnostic accuracy and utility of three dengue diagnostic tests
for the diagnosis of acute dengue infection in Malaysia. BMC Infectious
Diseases, 20(1), 210. https://doi.org/10.1186/s12879-020-4911-5
Eivazzadeh-Keihan, R., Pashazadeh-Panahi, P., Mahmoudi, T., Chenab, K. K.,
Baradaran, B., Hashemzaei, M., … Maleki, A. (2019). Dengue virus:
A review on advances in detection and trends – from conventional
methods to novel biosensors. Microchimica Acta, 186(6), 329. https://
doi.org/10.1007/s00604-019-3420-y
European Centre for Disease Prevention and Control (ECDC) 2022. (2022).
European Centre for Disease Prevention and Control: Dengue
Worldwide Overview. Retrieved from https://www.ecdc.europa.eu/
en/dengue-monthly
Guzman, M. G., Halstead, S. B., Artsob, H., Buchy, P., Farrar, J., Gubler, D. J.,
… Peeling, R. W. (2010). Dengue: A continuing global threat. Nature
10 Introduction to Dengue and Issues with Current Diagnostics
Dengue Diagnostics: The Right Test at the Right Time for the Right Group
Edited by Shamala Devi Sekaran
Copyright © 2024 Jenny Stanford Publishing Pte. Ltd.
ISBN 978-981-4968-97-3 (Hardcover), 978-1-032-66956-4 (eBook)
www.jennystanford.com
14 Traditional and Current Diagnosis
rapid, simple, and low cost. Newer detection methods for dengue
that can fill this acknowledged gap are urgently needed.
Common laboratory methods for diagnosing dengue include
virus isolation, detection of viral antigens, genomic detection by
molecular methods, and serology. Dengue diagnosis is divided
into two main phases: the early phase and the late phase. Different
laboratory methods are being used to diagnose dengue at different
phases of illness (Figure 2.1). In the early or febrile phase of illness,
the approaches of diagnosis are via viral isolation, RT-PCR, and
antigen detection, while the later phase is mainly through serology
(Shamala, 2015). For a diagnosis of ‘confirmed’ dengue, dengue virus
should be isolated or viral RNA amplified, or there should be a four-
fold rise in antibody titer in paired (acute and convalescent) serum
specimens, or demonstration of seroconversion from negative to
positive IgM antibody. Serological tests such as IgM Capture ELISA
are favorable, especially in hospitals of dengue-endemic countries
due to their inexpensiveness, simplicity, and narrow time frame of
viremia (Lee et al., 2011). Nevertheless, serological assays can be
a challenge in hyperendemic areas where pre-existing antibodies
complicate diagnosis (Sekaran et al., 2014). The choice of a test,
therefore, depends not only on the availability of facilities and
human resources but more importantly on the time of sampling.
oldest and least sensitive method for virus isolation. This method
is only used when no other methods are available. Nevertheless, it
offers the advantage of evaluating the neurotropic characteristics of
the dengue virus particle in vivo. Viruses are generally identified by
the immunofluorescence method using dengue-specific monoclonal
antibodies applied to the brain tissue of mice. Not all laboratories
house animal facilities nor the ready availability of suckling. As such,
storage of samples till the availability of the suckling would result in
a lower sensitivity especially when viral loads are low. The advantage
of using suckling mice is that other arboviruses that cause dengue-
like symptoms may be isolated with this system (See Appendix 1 for
protocol).
(Roche et al., 2000). However, these methods may not always work
especially when the viral loads are low. In a comparative study,
the virus isolation rate was found to be the highest in TRA-284,
followed by AP-61 and C6/36 (Kuno, Gubler, Vélez, & Oliver, 1985).
Nonetheless, C6/36 cells were favored for detecting infected cells by
the direct fluorescent antibody test. Problems with AP-61 and TRA-
284 are due to the frequent cell clumping and difficulties in forming
a monolayer in a cell culture flask. For all these techniques, skilled
and experienced personnel are needed to be able to recognize the
CPE and the type of immunofluorescence observed upon staining
with dengue-specific monoclonal antibodies (See Appendix 3 for
protocol).
Bioline Dengue NS1 Ag Rapid Test (Abbott, Abbott Park, IL, USA).
These tests are only used for diagnostic purposes and not as point-
of-care tests (Kabir, Zilouchian, Younas, & Asghar, 2021).
Principle of HI test.
Figure 2.2
22 Traditional and Current Diagnosis
urine, and serum) will be added with primer pairs and probes
which are specific to each dengue serotypes (DENV1- DENV4). The
use of fluorescent probe (e.g., SYBR green, Taqman®) enables the
detection and quantification (qRT-PCR) of the amplified product in
real time using PCR machine. Generally, compared to the SYBR green,
the TaqMan real-time PCR is highly specific as it uses the sequence-
specific hybridization of the probe. The available qRT-PCR include
the “singleplex” (detecting only one serotype) or “multiplex” (able to
identify all four serotypes in each single sample). A multiplex RT-PCR
assay using SYBR green probe was developed to determine all four
serotypes from the blood sample (Yong et al., 2007). The developed
assay had a sensitivity and specificity of 98.18% and 100%,
respectively. Another multiplex one-step RT-PCR assay has been
developed using TaqMan probe (see Appendix 4 for protocol) (Kong
et al., 2006). The assay uses a set of forward and reverse primers
designed to target serotype conserved region at the NS5 gene, and
simultaneously target a variable region for all four serotypes (sets
of primers that were previously used to design the serotype-specific
TaqMan probes). This assay had sensitivity, specificity, and real-time
PCR efficiency of 89.54%, 100%, and 91.5%, respectively. Currently,
there are two NAT assays approved by the FDA: CDC DENV-1-4
Real-Time RT-PCR Multiplex assay and Trioplex rRT-PCR Assay. The
former (differentiates all four serotypes) is used in cases where the
primary infection cause would be the DENV. The Trioplex rRT-PCR
Assays are used when Dengue, Chikungunya, and Zika are suspected,
allowing one to screen for all three viruses at the same time (Kabir
et al., 2021).
References
Alcon-LePoder, S., Sivard, P., Drouet, M.-T., Talarmin, A., Rice, C., &
Flamand, M. (2008). Secretion of Flaviviral Non-Structural Protein
NS1: From Diagnosis to Pathogenesis. pp. 233–250. https://doi.
org/10.1002/0470058005.ch17
Amaral, D. C., Rachid, M. A., Vilela, M. C., Campos, R. D., Ferreira, G. P.,
Rodrigues, D. H., …, & Teixeira, A. L. (2011). Intracerebral infection
with dengue-3 virus induces meningoencephalitis and behavioral
changes that precede lethality in mice. Journal of Neuroinflammation,
8(1), 23. https://doi.org/10.1186/1742-2094-8-23
Balsitis, S. J., Coloma, J., Castro, G., Alava, A., Flores, D., McKerrow, J. H., …,
& Harris, E. (2009). Tropism of dengue virus in mice and humans
defined by viral nonstructural protein 3-specific immunostaining. The
American Journal of Tropical Medicine and Hygiene, 80(3), 416–424
Bhalla, N., Jolly, P., Formisano, N., & Estrela, P. (2016). Introduction
to biosensors. Essays in Biochemistry, 60(1), 1–8. https://doi.
org/10.1042/EBC2015000
Blacksell, S. D., Jarman, R. G., Gibbons, R. V., Tanganuchitcharnchai, A.,
Mammen, M. P., Jr, Nisalak, A., Kalayanarooj, S., Bailey, M. S., Premaratna,
R., de Silva, H. J., Day, N. P., & Lalloo, D. G. (2012). Comparison of seven
commercial antigen and antibody enzyme-linked immunosorbent
assays for detection of acute dengue infection. Clinical and Vaccine
Immunology: CVI, 19(5), 804–810. https://doi.org/10.1128/
CVI.05717-11
Bourgeois, M. A., & Oaks, J. L. (2014). Laboratory diagnosis of viral infections.
In Equine Infectious Diseases. pp. 132–140.e2. Elsevier. https://doi.
org/10.1016/B978-1-4557-0891-8.00012-9
Chong, Z. L., Soe, H. J., Ismail, A. A., Mahboob, T., Chandramathi, S., & Sekaran,
S. D. (2021). Evaluation of the diagnostic accuracy of a new biosensors-
based rapid diagnostic test for the point-of-care diagnosis of previous
and recent dengue infections in Malaysia. Biosensors, 11, 129. https://
doi.org/10.3390/bios11050129
Choy, M. M., Ellis, B. R., Gubler, D. J., & Ellis, E. M. (2013). Comparison of the
mosquito inoculation technique and quantitative real time polymerase
chain reaction to measure dengue virus concentration. The American
References 29
Henchal, E. A., & Putnak, J. R. (1990). The dengue viruses. Clinical Microbiology
Reviews, 3(4), 376–396. https://doi.org/10.1128/CMR.3.4.376
Hunsperger, E. A., Yoksan, S., Buchy, P., Nguyen, V. C., Sekaran, S. D., Enria,
D. A., Pelegrino, J. L., Vázquez, S., Artsob, H., Drebot, M., Gubler, D. J.,
Halstead, S. B., Guzmán, M. G., Margolis, H. S., Nathanson, C. M., Rizzo
Lic, N. R., Bessoff, K. E., Kliks, S., & Peeling, R. W. (2009). Evaluation
of commercially available anti-dengue virus immunoglobulin M
tests. Emerging infectious diseases, 15(3), 436–440. https://doi.
org/10.3201/eid1503.080923
Igarashi, A. (1978). Isolation of a Singh’s Aedes albopictus cell clone sensitive
to dengue and chikungunya viruses. Journal of General Virology, 40(3),
531–544. https://doi.org/10.1099/0022-1317-40-3-531
Jittmittraphap, A., Thammapalo, S., Ratanasetyuth, N., Wongba, N., Mammen,
M. P., & Jampangern, W. (2006). Rapid detection of dengue viral RNA
in mosquitoes by nucleic acid-sequence based amplification (NASBA).
The Southeast Asian Journal of Tropical Medicine and Public Health,
37(6), 1117–1124.
Kabir, M. A., Zilouchian, H., Younas, M. A., & Asghar, W. (2021). Dengue
detection: Advances in diagnostic tools from conventional technology
to point of care. Biosensors, 11(7), 206. https://doi.org/10.3390/
bios11070206
Kao, C.-L., King, C.-C., Chao, D.-Y., Wu, H.-L., & Chang, G.-J. J. (2005). Laboratory
diagnosis of dengue virus infection: current and future perspectives
in clinical diagnosis and public health. Journal of Microbiology,
Immunology, and Infection, 38(1), 5–16.
Kao, C.-L., Wu, M.-C., Chiu, Y.-H., Lin, J.-L., Wu, Y.-C., Yueh, Y.-Y., …, & King, C.-
C. (2001). Flow cytometry compared with indirect immunofluorescence
for rapid detection of dengue virus type 1 after amplification in tissue
culture. Journal of Clinical Microbiology, 39(10), 3672–3677. https://
doi.org/10.1128/JCM.39.10.3672-3677.2001
Kassim, F. M., Izati, M. N., TgRogayah, T. A. R., Apandi, Y. M., & Saat, Z.
(2011). Use of dengue NS1 antigen for early diagnosis of dengue virus
infection. The Southeast Asian Journal of Tropical Medicine and Public
Health, 42(3), 562–569.
Kikuti, M., Cruz, J. S., Rodrigues, M. S., Tavares, A. S., Paploski, I. A. D., Silva,
M. M. O., Santana, P. M., Tauro, L. B., Silva, G. A. O. F., Campos, G. S.,
Araújo, J. M. G., Kitron, U., Reis, M. G., & Ribeiro, G. S. (2019). Accuracy
of the SD BIOLINE Dengue Duo for rapid point-of-care diagnosis of
dengue. PloS One, 14(3), e0213301. https://doi.org/10.1371/journal.
pone.0213301
References 31
Kong, Y. Y., Thay, C. H., Tin, T. C., & Devi, S. (2006). Rapid detection, serotyping
and quantitation of dengue viruses by TaqMan real-time one-step RT-
PCR. Journal of Virological Methods, 138(1–2), 123–130. https://doi.
org/10.1016/j.jviromet.2006.08.003
Kumarasamy, V., Wahab, A. H. A., Chua, S. K., Hassan, Z., Chem, Y. K., Mohamad,
M., & Chua, K. B. (2007). Evaluation of a commercial dengue NS1
antigen-capture ELISA for laboratory diagnosis of acute dengue virus
infection. Journal of Virological Methods, 140(1–2), 75–79. https://doi.
org/10.1016/j.jviromet.2006.11.001
Kuno, G., Gubler, D. J., Vélez, M., & Oliver, A. (1985). Comparative sensitivity
of three mosquito cell lines for isolation of dengue viruses. Bulletin of
the World Health Organization, 63(2), 279–286.
Lam, S. K., Chew, C. B., Poon, G. K., Ramalingam, S., Seow, S. C., & Pang, T.
(1986). Isolation of dengue viruses by intracerebral inoculation of
mosquito larvae. Journal of Virological Methods, 14(2), 133–140.
https://doi.org/10.1016/0166-0934(86)90044-3
Lee, L. K., Thein, T. L., Kurukularatne, C., Gan, V. C., Lye, D. C., & Leo, Y. S.
(2011). Dengue knowledge, attitudes, and practices among primary
care physicians in Singapore. Annals of the Academy of Medicine,
Singapore, 40(12), 533–538.
Namekar, M., Ellis, E. M., O’Connell, M., Elm, J., Gurary, A., Park, S. Y., Imrie, A.,
& Nerurkar, V. R. (2013). Evaluation of a new commercially available
immunoglobulin M capture enzyme-linked immunosorbent assay for
diagnosis of dengue virus infection. Journal of Clinical Microbiology,
51(9), 3102–3106. https://doi.org/10.1128/JCM.00351-13
Nakao, S., Lai, C. J., & Young, N. S. (1989). Dengue virus, a flavivirus,
propagates in human bone marrow progenitors and hematopoietic
cell lines. Blood, 74(4), 1235–1240.
Notomi, T. (2000). Loop-mediated isothermal amplification of DNA. Nucleic
Acids Research, 28(12), 63e–63. https://doi.org/10.1093/nar/28.12.
e63
Oliveira De Paula, S., Malta Lima, D., Clotteau, M., Pires Neto, R. da J., &
Lopes da Fonseca, B. A. (2003). Improved detection of dengue-1
virus from IgM-positive serum samples using C6/36 cell cultures in
association with RT-PCR. Intervirology, 46(4), 227–231. https://doi.
org/10.1159/000072432
Peeling, R. W., Artsob, H., Pelegrino, J. L., Buchy, P., Cardosa, M. J., Devi, S.,
…, & Yoksan, S. (2010). Evaluation of diagnostic tests: Dengue. Nature
Reviews Microbiology, 8(S12), S30–S37. https://doi.org/10.1038/
nrmicro2459
32 Traditional and Current Diagnosis
Philip Samuel, P., & Tyagi, B. K. (2006). Diagnostic methods for detection &
isolation of dengue viruses from vector mosquitoes. The Indian Journal
of Medical Research, 123(5), 615–628.
Prince, H. E., Yeh, C., & Lapé-Nixon, M. (2011). Utility of IgM/IgG ratio and
IgG avidity for distinguishing primary and secondary dengue virus
infections using sera collected more than 30 days after disease onset.
Clinical and Vaccine Immunology: CVI, 18(11), 1951–1956. https://doi.
org/10.1128/CVI.05278-11
Rathakrishnan, A., & Sekaran, S. D. (2013). New development in the
diagnosis of dengue infections. Expert Opinion on Medical Diagnostics,
7(1), 99–112. https://doi.org/10.1517/17530059.2012.718759
Roche, R. R., Alvarez, M., Guzmán, M. G., Morier, L., & Kourí, G. (2000).
Comparison of rapid centrifugation assay with conventional tissue
culture method for isolation of dengue 2 virus in C6/36-HT cells.
Journal of Clinical Microbiology, 38(9), 3508–3510. https://doi.
org/10.1128/JCM.38.9.3508-3510.2000
Sekaran, S. D., Rathakrishnan, A., & Yeo, A. S. L. (2014). Dengue: An overview.
Journal of Health and Translational Medicine, 17(2), 1–10. https://doi.
org/10.22452/jummec.vol17no2.1
Shamala, D. S. (2015). Laboratory diagnosis of dengue: A review. International
Medical Journal Malaysia, 14(1), 17–28. https://doi.org/10.31436/
imjm.v14i1.452
Shu, P.-Y., & Huang, J.-H. (2004). Current advances in dengue diagnosis.
Clinical and Vaccine Immunology, 11(4), 642–650. https://doi.
org/10.1128/ CDLI.11.4.642-650.2004
Singharaj, P., Simasathien, P., Sukhavachana, P., Halstead, S. B., & Scanlon, J.
E. (1966). Recovery of dengue and other viruses in mice and tissue
culture from Thai mosquitos. Bulletin of the World Health Organization,
35(1), 67–68.
Tricou, V., Vu, H. T., Quynh, N. V., Nguyen, C. V., Tran, H. T., Farrar, J., …, &
Simmons, C. P. (2010). Comparison of two dengue NS1 rapid
tests for sensitivity, specificity and relationship to viraemia and
antibody responses. BMC Infectious Diseases, 10(1), 142. https://doi.
org/10.1186/1471-2334-10-142
Usawattanakul, W., & P, A. J. T. (2002). Rapid detection of dengue viral RNA by
nucleic acid sequence-based amplification (NASBA), 26(2), 125–130.
Velez, M., Kuno, G., Gubler, D. J., Oliver, A., & Sather, G. E. (1984). Mosquito cell
cultures and specific monoclonal antibodies in surveillance for dengue
viruses. The American Journal of Tropical Medicine and Hygiene, 33(1),
158–165. https://doi.org/10.4269/ajtmh.1984.33.158
References 33
Dengue Diagnostics: The Right Test at the Right Time for the Right Group
Edited by Shamala Devi Sekaran
Copyright © 2024 Jenny Stanford Publishing Pte. Ltd.
ISBN 978-981-4968-97-3 (Hardcover), 978-1-032-66956-4 (eBook)
www.jennystanford.com
36 Newer Diagnostics for Dengue Disease